KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Idexx Laboratories (IDXX) over the last 16 years, with Q3 2025 value amounting to $81.2 million.

  • Idexx Laboratories' Shares Outstanding (Diluted Average) fell 272.05% to $81.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.2 million, marking a year-over-year decrease of 272.05%. This contributed to the annual value of $83.2 million for FY2024, which is 87.17% down from last year.
  • Latest data reveals that Idexx Laboratories reported Shares Outstanding (Diluted Average) of $81.2 million as of Q3 2025, which was down 272.05% from $81.5 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Shares Outstanding (Diluted Average) registered a high of $86.9 million during Q1 2021, and its lowest value of $81.2 million during Q3 2025.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $84.3 million, with a median of $84.0 million in 2023.
  • As far as peak fluctuations go, Idexx Laboratories' Shares Outstanding (Diluted Average) increased by 26.11% in 2021, and later crashed by 272.05% in 2025.
  • Idexx Laboratories' Shares Outstanding (Diluted Average) (Quarter) stood at $86.6 million in 2021, then decreased by 2.28% to $84.6 million in 2022, then dropped by 0.74% to $84.0 million in 2023, then dropped by 0.87% to $83.2 million in 2024, then fell by 2.45% to $81.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $81.2 million for Q3 2025, versus $81.5 million for Q2 2025 and $81.9 million for Q1 2025.